Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Soumerai, J. D.
137  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

P687: A PHASE 1 STUDY WITH THE NOVEL B-CELL LYMPHOMA 2 (BCL..:

S. Opat ; C. Y. Cheah ; M. Lasica...
http://journals.lww.com/10.1097/01.HS9.0000845632.15209.07.  , 2022
Link: https://doi.org/10.1097/..
 
?
2

P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT ..:

Soumerai, J. D ; Jagadeesh, D ; Salman, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430341/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

P1114: ZANDELISIB ON INTERMITTENT DOSING AS A SINGLE AGENT ..:

J. D. Soumerai ; D. Jagadeesh ; H. Salman...
http://journals.lww.com/10.1097/01.HS9.0000847324.06186.df.  , 2022
Link: https://doi.org/10.1097/..
 
?
4

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Pati..:

Roeker, Lindsey E ; Feldman, Tatyana A ; Soumerai, Jacob D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481719/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

AKT mutant allele-specific activation dictates pharmacologi..:

Shrestha Bhattarai, Tripti ; Shamu, Tambudzai ; Gorelick, Alexander N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018718/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Effect of granulocyte colony-stimulating factor on toxiciti..:

Miller, Kevin Charles ; Johnson, Patrick Connor ; Abramson, Jeremy S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622902/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

The impact of anti-CD20-based therapy on hypogammaglobuline..:

Fischer, Thaís ; Ni, Andy ; Bantilan, Kurt S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754062/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Next-generation ALK inhibitors are highly active in ALK-pos..:

Soumerai, Jacob D ; Rosenthal, Allison ; Harkins, Shannon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837428/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Zanubrutinib, obinutuzumab, and venetoclax with minimal res..:

Soumerai, Jacob D ; Mato, Anthony R ; Dogan, Ahmet...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326222/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

OncoTree: A Cancer Classification System for Precision Onco..:

Kundra, Ritika ; Zhang, Hongxin ; Sheridan, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240791/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

National Prevalence of Problems Paying Medical Bills and Co..:

Madden, J ; Bayapureddy, S ; Briesacher, B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440429/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
12

Follicular lymphoma in the modern era: survival, treatment ..:

Batlevi, Connie L ; Sha, Fushen ; Alperovich, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366724/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Time from diagnosis to 2nd treatment is a promising surroga..:

Soumerai, Jacob D ; Ni, Andy ; Alperovich, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335705/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Risk Model for Overall Survival in Relapsed or Refractory C..:

Soumerai, Jacob D ; Ni, Ai ; Darif, Mohamed...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620111/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

A methodological framework for model selection in interrupt..:

Lopez Bernal, J ; Soumerai, S ; Gasparrini, A
https://researchonline.lshtm.ac.uk/id/eprint/4648066/1/A-Methodological-Framework-for-Model-Selection-in-Interrupted-Time-Series-Studies.pdf.  , 2018
Link: https://researchonline.l..
 
1-15